Nucleotide substitution patterns can predict the requirements for drug-resistance of HIV-1 proteins
Authors:
- Ben BerkhoutBBBen Berkhout
- 1 June 1996
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 31 (1-2) , 45-57
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Revertants and pseudo-revertants of human immunodeficiency virus type 1 viruses mutated in the long terminal repeat promoter regionJournal of General Virology, 1995
- Mutational sensitivity patterns define critical residues in the palm subdomain of the reverse transcriptase of human immunodeficiency virus type 1Nucleic Acids Research, 1995
- HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and TherapyScience, 1995
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Mutational Analysis of the Fingers and Palm Subdomains of Human Immunodeficiency Virus Type-1 (HIV-1) Reverse TranscriptaseJournal of Molecular Biology, 1994
- Fidelity of HIV-1 Reverse Transcriptase Copying a Hypervariable Region of the HIV-1 env GeneVirology, 1994
- Failure of Antiretroviral Therapy: Role of Viral and Cellular FactorsIntervirology, 1994
- High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptaseAntimicrobial Agents and Chemotherapy, 1993
- The same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine confers high-level resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidineAntimicrobial Agents and Chemotherapy, 1993
- Patterns of nucleotide substitution in pseudogenes and functional genesJournal of Molecular Evolution, 1982